Today: 13 June 2026
KLA Jumps After 10-for-1 Stock Split; AI Chip Boom Lifts Hopes on Tools
13 June 2026
2 mins read

KLA Jumps After 10-for-1 Stock Split; AI Chip Boom Lifts Hopes on Tools

New York, June 12, 2026, 20:15 (EDT)

  • KLA finished Friday at $254.54, gaining 5.55% in its first session after the stock split.
  • The move came after a 10-for-1 stock split and new analyst price targets, as AI demand boosted semiconductor equipment outlooks.
  • KLA’s fiscal fourth-quarter report is the next big catalyst, with investors watching for guidance updates on demand, margins, and AI-related wafer-fab spending.

KLA Corporation finished Friday at $254.54, gaining 5.55%. Shares started at $237.60 and hit a session high of $254.93. The stock, which is in the Nasdaq-100 and S&P 500, has surged about 19% in two days after its split adjustment. The rally comes as investors reprice chip-equipment makers linked to AI demand. Stocks go up when buyers pay more for future earnings, cash flow or growth, and fall when those expectations drop or valuations get too high.

KLA’s 10-for-1 stock split took effect at the open on June 12, with each existing share turning into 10 new shares. The company said the total value of any investor’s position should stay the same. KLA said the split doesn’t change its total market cap or the percentage of the company that investors own. “This stock split is intended to improve the accessibility and liquidity of KLA shares, while maintaining consistency with our long-term capital allocation strategy,” CFO Bren Higgins said. KLA Corporation

The split doesn’t make KLA shares cheaper on fundamentals. But lowering the share price can drum up more interest from retail investors and employees. The main driver is still the market’s view that KLA’s inspection and process-control gear is essential for advanced chipmaking. In April, Reuters said KLA tools catch microscopic chip defects. As AI chips get more complex, chipmakers need even more inspection and measurement — what the industry calls “process-control intensity.” Reuters

KLA got a boost from analyst moves. MarketScreener had Barclays lifting its price target to $2,250 from $1,700, staying Overweight. Cantor Fitzgerald pushed its target up to $2,500 from $2,000, also Overweight. UBS raised to $2,180 from $1,770 but kept a Neutral. Since these price targets came out near the time of the stock split, investors should look at them on a split-adjusted basis: about $225, $250 and $218. With shares closing Friday at $254.54, that doesn’t leave much room, despite what unadjusted targets might show.

KLA’s fundamentals stayed solid in the fiscal third quarter. The company posted revenue of $3.415 billion and GAAP net income of $1.20 billion. GAAP diluted earnings per share hit $9.12. On an adjusted basis, non-GAAP diluted EPS was $9.40. Looking at the fiscal fourth quarter ending in June, KLA guided revenue to $3.575 billion, give or take $200 million, and sees non-GAAP diluted EPS at $9.87, give or take $1.00. Gross margin is set to stay above 60%, which KLA says shows its pricing strength for specialized chip equipment.

KLA is seen as one of the best ways to get exposure to AI infrastructure spending if you don’t want to hold a chip designer. The bull view bets that if foundry, memory, and advanced-packaging customers keep ramping up, orders for KLA’s defect-detection and process-control tools should remain strong. KLA is also giving cash back to shareholders. For its fiscal third quarter, capital returns hit $874.8 million, with $3.15 billion sent back over the past year. The board just signed off on another $7 billion share buyback and boosted the quarterly dividend. Buybacks can lift earnings per share by shrinking the float but don’t cut business-cycle risk.

KLA shares are expensive by standard measures, with Fidelity pegging the price-to-earnings ratio around 68. That means buyers are paying about 68 times recent earnings. But MarketScreener has the average analyst target at $192.62, while the stock last closed at $254.54—well above that, despite a still-positive consensus. Reuters pointed out that shares dropped nearly 9% after April’s earnings when the outlook wasn’t strong enough for some investors. Even with a good company, expectations can get too high.

KLA’s next key event is its fiscal fourth-quarter update once the June quarter wraps up. Investors are focused on whether revenue beats the $3.575 billion midpoint, if non-GAAP EPS tops $9.87, and what management says about AI, advanced packaging, and memory equipment demand easing margin and export risks. The stock surged in two days and now sits above several adjusted target levels. New buyers face more risk here, but the long-term bull thesis still holds if the AI cycle keeps widening.

Stock Market Today

  • Cintas (CTAS) Stock Valuation Mixed Amid UniFirst Deal Expectations
    June 13, 2026, 3:33 PM EDT. Cintas Corp (CTAS) stock closed at $176.28, reflecting mixed returns with a 2% decline over the past week and a 4.7% drop year to date, despite gains over three and five years. Investors are reassessing value amid maturity in the service sector and deal expectations with UniFirst. A Discounted Cash Flow (DCF) analysis estimates Cintas' intrinsic value at $187.68 per share, indicating the stock trades at a 6.1% discount and suggesting it is fairly valued. The company scored 2 out of 6 on value checks, highlighting some undervaluation but signaling caution. Market watchers are urged to monitor shifts in assumptions that could affect valuations and consider the broader strategic narrative beyond the numbers.

Latest articles

KLA Jumps After 10-for-1 Stock Split; AI Chip Boom Lifts Hopes on Tools

KLA Jumps After 10-for-1 Stock Split; AI Chip Boom Lifts Hopes on Tools

13 June 2026
KLA soared 5.55% to $254.54 on its first split-adjusted day after a 10-for-1 stock split and analyst price target hikes tied to AI-driven chip equipment demand, but with the stock now above several split-adjusted targets, investors face heightened risk ahead of the fiscal Q4 report, which will be the next key catalyst for revenue, earnings, and AI-linked demand guidance.
Pfizer trades around $26 with dividend in focus, drug-price worries linger

Pfizer trades around $26 with dividend in focus, drug-price worries linger

13 June 2026
Pfizer closed at $26.21, up 0.15%, outperforming the Health Care Select Sector SPDR ETF despite new German drug-pricing pressures and a European legal setback; investors are focused on the 6.56% dividend yield, reaffirmed 2026 guidance, and pipeline progress in obesity and oncology as Q2 earnings on August 4 approach.
Altria Stock Rebounds Near Ex-Dividend Date as MO Investors Weigh Yield, Valuation and July Earnings
Previous Story

Altria Stock Rebounds Near Ex-Dividend Date as MO Investors Weigh Yield, Valuation and July Earnings

Go toTop